Baiyi culture medi development Co.,LTD (formerly known as Shenzhen Zhengda Xingtai Advertising Co., Ltd.), established in 2009 and located in Shenzhen, Guangdong Province, is an enterprise mainly engaged in business services with a registered capital of 5 million RMB and a paid in capital of 1 million RMB.
Our core values of "innovation, collaboration, integrity, and responsibility" are upheld, and we are committed to providing customers with high-quality products and services
The company adheres to the core values of "innovation, collaboration, integrity, and responsibility" and is committed to providing customers with high-quality products and services
Longhua Tangcheng Project Real Estate Exhibition Tour - Longhua Tianhong Shopping Center
The Shenzhen Property Binhai Port project covers an area of approximately 51700 square meters, with a plot ratio of 2.2 and a total construction area of approximately 165900 square meters. The total construction area of high-rise residential buildings is approximately 108800 square meters, with a planned total of 12 high-rise residential towers ranging from 16 to 18 floors (excluding 1 residential building) and 12 community kindergartens. The project aims to create 856 high-end, low-density and comfortable homes with a construction area of approximately 95-143 square meters.
Longhua Tangcheng Project Real Estate Exhibition Tour - Yinli Center
Shenzhen Yinli Center (formerly Shenzhen Shenguotou Plaza) is located in Futian District and is a shopping center that integrates leisure, shopping, entertainment, catering, and office. Yinli Center has the first Sam's Club membership store in China and is also the first shopping center in Xiangmihu, Shenzhen.
Jindi Chenfeng Mansion Project Real Estate Exhibition Tour
The Shenzhen Property Binhai Port project covers an area of approximately 51700 square meters, with a plot ratio of 2.2 and a total construction area of approximately 165900 square meters. The total construction area of high-rise residential buildings is approximately 108800 square meters, with a planned total of 12 high-rise residential towers ranging from 16 to 18 floors (excluding 1 residential building) and 12 community kindergartens. The project aims to create 856 high-end, low-density and comfortable homes with a construction area of approximately 95-143 square meters.
Meishengling Shangyuan
Meishengling Shangyuan is located on the east side of the intersection of Longfeng Road and Longping Road in Longgang District. The construction land area of the project is 14873.47 square meters, with a total construction area of 103777.55 square meters. It consists of 5 main buildings, with a total of 715 housing units, including 439 sellable commercial housing units, 199 affordable housing units, 77 self owned rental housing units, 727 motor vehicle parking spaces, and a plot ratio of 4.87.
Our team adheres to the core values of "innovation, collaboration, integrity, and responsibility" and is committed to providing customers with high-quality products and services
With over 20 years of experience in new drug research and production management, he has played an important role in the development and commercialization of multiple global new drugs. The Medicine Maker 2020 "Top 20 Most Influential Figures in the Global Small Molecule Field" and 2019 "Top 100 Most Influential Figures in the Global Pharmaceutical Industry". Prior to joining the company, served as the Director of Technical Operations for a US company. Obtained a Bachelor's degree in Chemistry from Peking University and a PhD in Organic Chemistry from the University of Minnesota.
I graduated from Chuzhou University in 1995 and obtained a Master's degree in Vocational Education from Beijing Normal University in 2013. I am a national first-class construction engineer, senior urban planner, and standardization expert. I have expertise in architecture, planning, education, urban transportation, technology transfer, and literature
With over 20 years of experience in new drug research and production management, he has played an important role in the development and commercialization of multiple global new drugs. The Medicine Maker 2020 "Top 20 Most Influential Figures in the Global Small Molecule Field" and 2019 "Top 100 Most Influential Figures in the Global Pharmaceutical Industry". Prior to joining the company, served as the Director of Technical Operations for a US company. Obtained a Bachelor's degree in Chemistry from Peking University and a PhD in Organic Chemistry from the University of Minnesota.
With over 20 years of experience in new drug research and production management, he has played an important role in the development and commercialization of multiple global new drugs. The Medicine Maker 2020 "Top 20 Most Influential Figures in the Global Small Molecule Field" and 2019 "Top 100 Most Influential Figures in the Global Pharmaceutical Industry". Prior to joining the company, served as the Director of Technical Operations for a US company. Obtained a Bachelor's degree in Chemistry from Peking University and a PhD in Organic Chemistry from the University of Minnesota.
With over 20 years of experience in new drug research and production management, he has played an important role in the development and commercialization of multiple global new drugs. The Medicine Maker 2020 "Top 20 Most Influential Figures in the Global Small Molecule Field" and 2019 "Top 100 Most Influential Figures in the Global Pharmaceutical Industry". Prior to joining the company, served as the Director of Technical Operations for a US company. Obtained a Bachelor's degree in Chemistry from Peking University and a PhD in Organic Chemistry from the University of Minnesota.
Follow Baiyi
